IGC Pharma Inc (IGC)
0.4451
-0.04
(-9.16%)
USD |
NYAM |
Apr 22, 16:00
0.4434
0.00 (0.00%)
Pre-Market: 09:04
IGC Pharma Cash from Operations (TTM): -6.19M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.19M |
| September 30, 2023 | -6.251M |
| June 30, 2023 | -6.319M |
| March 31, 2023 | -7.047M |
| December 31, 2022 | -6.417M |
| September 30, 2022 | -7.191M |
| June 30, 2022 | -7.807M |
| March 31, 2022 | -7.462M |
| December 31, 2021 | -9.08M |
| September 30, 2021 | -8.503M |
| June 30, 2021 | -8.663M |
| March 31, 2021 | -10.80M |
| December 31, 2020 | -10.29M |
| September 30, 2020 | -10.68M |
| June 30, 2020 | -9.793M |
| March 31, 2020 | -8.677M |
| December 31, 2019 | -7.832M |
| September 30, 2019 | -6.923M |
| June 30, 2019 | -5.667M |
| March 31, 2019 | -3.33M |
| December 31, 2018 | -3.14M |
| September 30, 2018 | -2.155M |
| June 30, 2018 | -1.944M |
| March 31, 2018 | -1.931M |
| December 31, 2017 | -1.881M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.341M |
| June 30, 2017 | -2.116M |
| March 31, 2017 | -1.391M |
| December 31, 2016 | -0.6448M |
| September 30, 2016 | -0.8418M |
| June 30, 2016 | 0.5937M |
| March 31, 2016 | -0.1577M |
| December 31, 2015 | -0.452M |
| September 30, 2015 | -0.6242M |
| June 30, 2015 | -2.565M |
| March 31, 2015 | -2.584M |
| December 31, 2014 | -3.003M |
| September 30, 2014 | -3.278M |
| June 30, 2014 | -2.066M |
| March 31, 2014 | -1.742M |
| December 31, 2013 | -1.562M |
| September 30, 2013 | 0.3846M |
| June 30, 2013 | 0.4018M |
| March 31, 2013 | 0.5648M |
| December 31, 2012 | -2.564M |
| September 30, 2012 | -4.444M |
| June 30, 2012 | -4.678M |
| March 31, 2012 | -5.022M |
| December 31, 2011 | -1.627M |
| September 30, 2011 | -1.637M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-10.80M
Minimum
Mar 2021
-5.667M
Maximum
Jun 2019
-7.979M
Average
-7.807M
Median
Jun 2022
Cash from Operations (TTM) Benchmarks
| CEL-SCI Corp | -23.07M |
| AIM ImmunoTech Inc | -21.27M |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Protalix BioTherapeutics Inc | -1.318M |
| Palatin Technologies Inc | -26.54M |